US2390529A
(en)
|
1942-02-03 |
1945-12-11 |
Ernst A H Friedheim |
Hydrazino-1,3,5-triazino derivatives of substituted phenylarsenic compounds
|
US2913408A
(en)
|
1956-12-28 |
1959-11-17 |
Dow Chemical Co |
Corrosion inhibitors for ferrous metals in aqueous solutions of non-oxidizing acids
|
DE1252823B
(sr)
|
1963-02-15 |
|
|
|
BE754242A
(fr)
|
1970-07-15 |
1971-02-01 |
Geigy Ag J R |
Diamino-s-triazines et dinitro-s-triazines
|
US3867383A
(en)
|
1971-03-29 |
1975-02-18 |
Ciba Geigy Corp |
Monoanthranilatoanilino-s-triazines
|
BE793501A
(fr)
|
1971-12-31 |
1973-06-29 |
Ciba Geigy |
Composes heterocycliques et produits phytopharmaceutiques qui en contiennent
|
CH606334A5
(sr)
|
1974-06-21 |
1978-10-31 |
Ciba Geigy Ag |
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
JPS58186682A
(ja)
|
1982-04-27 |
1983-10-31 |
日本化薬株式会社 |
セルロ−ス又はセルロ−ス含有繊維材料の染色法
|
JPS59151784U
(ja)
|
1983-03-30 |
1984-10-11 |
日産自動車株式会社 |
トラツクのリヤボデイ構造
|
DE3512630A1
(de)
|
1985-04-06 |
1986-10-23 |
Hoechst Ag, 6230 Frankfurt |
Verfahren zum faerben oder bedrucken von cellulosefasern oder cellulosemischfasern
|
US5041443A
(en)
|
1989-02-21 |
1991-08-20 |
Dainippon Pharmaceutical Co., Ltd. |
Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof
|
DE69010232T2
(de)
|
1989-03-03 |
1994-12-01 |
Dainippon Pharmaceutical Co |
2-(1-Piperazinyl)-4-phenylcycloalkanpyridin-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
|
JPH0499768A
(ja)
|
1990-08-17 |
1992-03-31 |
Dainippon Pharmaceut Co Ltd |
4―(4―フェニルピリジン―2―イル)ピペラジン―1―オキシド誘導体
|
JPH05140126A
(ja)
|
1991-11-26 |
1993-06-08 |
Hokko Chem Ind Co Ltd |
トリアゾール誘導体および除草剤
|
WO1993017009A1
(en)
|
1992-02-28 |
1993-09-02 |
Zenyaku Kogyo Kabushiki Kaisha |
s-TRIAZINE DERIVATIVE AND REMEDY FOR ESTROGEN-DEPENDENT DISEASES CONTAINING THE SAME AS ACTIVE INGREDIENT
|
IL115420A0
(en)
|
1994-09-26 |
1995-12-31 |
Zeneca Ltd |
Aminoheterocyclic derivatives
|
IL117580A0
(en)
|
1995-03-29 |
1996-07-23 |
Merck & Co Inc |
Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them
|
FR2735127B1
(fr)
|
1995-06-09 |
1997-08-22 |
Pf Medicament |
Nouvelles piperazines heteroaromatiques utiles comme medicaments.
|
ES2100129B1
(es)
|
1995-10-11 |
1998-02-16 |
Medichem Sa |
Nuevos compuestos aminopiridinicos policiclicos inhibidores de acetilcolinesterasa, procedimiento para su preparacion y su utilizacion.
|
WO1997028128A1
(en)
|
1996-02-02 |
1997-08-07 |
Zeneca Limited |
Heterocyclic compounds useful as pharmaceutical agents
|
GB9602166D0
(en)
|
1996-02-02 |
1996-04-03 |
Zeneca Ltd |
Aminoheterocyclic derivatives
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
JPH09291034A
(ja)
|
1996-02-27 |
1997-11-11 |
Yoshitomi Pharmaceut Ind Ltd |
縮合ピリジン化合物およびその医薬としての用途
|
US6262113B1
(en)
|
1996-03-20 |
2001-07-17 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
US5834485A
(en)
|
1996-05-20 |
1998-11-10 |
Chiroscience Limited |
Quinoline sulfonamides and their therapeutic use
|
US5984882A
(en)
|
1996-08-19 |
1999-11-16 |
Angiosonics Inc. |
Methods for prevention and treatment of cancer and other proliferative diseases with ultrasonic energy
|
CA2271744A1
(en)
|
1996-11-14 |
1998-05-22 |
Isao Hashiba |
Cyanoethylmelamine derivatives and process for producing the same
|
US6399358B1
(en)
|
1997-03-31 |
2002-06-04 |
Thomas Jefferson University |
Human gene encoding human chondroitin 6-sulfotransferase
|
CA2290624C
(en)
|
1997-06-06 |
2006-12-05 |
John W. Shell |
Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs
|
US6635280B2
(en)
|
1997-06-06 |
2003-10-21 |
Depomed, Inc. |
Extending the duration of drug release within the stomach during the fed mode
|
PT901786E
(pt)
|
1997-08-11 |
2007-08-07 |
Pfizer Prod Inc |
Disperções farmacêuticas sólidas com biodisponibilidade melhorada
|
JPH11158073A
(ja)
|
1997-09-26 |
1999-06-15 |
Takeda Chem Ind Ltd |
アデノシンa3拮抗剤
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
PT1042305E
(pt)
|
1997-12-22 |
2005-10-31 |
Bayer Pharmaceuticals Corp |
Inibicao de quinase p38 utilizando difenilureias simetricas e assimetricas
|
AU9064598A
(en)
|
1998-07-10 |
2000-02-01 |
Harald Groger |
Precusors for pna-monomers
|
CN1264575C
(zh)
|
1998-08-06 |
2006-07-19 |
山景药品公司 |
聚乙二醇或聚环氧乙烷-尿酸氧化酶结合物及其应用
|
US6783965B1
(en)
|
2000-02-10 |
2004-08-31 |
Mountain View Pharmaceuticals, Inc. |
Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
|
UY25842A1
(es)
|
1998-12-16 |
2001-04-30 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
US6274620B1
(en)
|
1999-06-07 |
2001-08-14 |
Biochem Pharma Inc. |
Thiophene integrin inhibitors
|
IL148243A0
(en)
|
1999-08-27 |
2002-09-12 |
Sugen Inc |
Trifluoromethyl sulfonyl and trifluoromethyl sulfonamido compounds and pharmaceutical compositions containing the same
|
KR100760434B1
(ko)
|
1999-09-17 |
2007-10-04 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
벤즈아미드 및 관련된 Xa 인자의 억제제
|
NZ517828A
(en)
|
1999-09-17 |
2003-10-31 |
Millennium Pharm Inc |
Inhibitors having activity against mammalian factor Xa
|
EP1242385B1
(en)
|
1999-12-28 |
2009-11-25 |
Pharmacopeia, Inc. |
Cytokine, especially tnf-alpha, inhibitors
|
MXPA02007254A
(es)
|
2000-02-04 |
2002-12-09 |
Depomed Inc |
Forma de dosis de cubierta-y-nucleo que se aproxima a liberacion de droga de orden cero.
|
DK1259485T3
(da)
|
2000-02-29 |
2006-04-10 |
Millennium Pharm Inc |
Benzamider og beslægtede inhibitorer for faktor Xa
|
AU8066701A
(en)
|
2000-07-20 |
2002-02-05 |
Neurogen Corp |
Capsaicin receptor ligands
|
JP4113323B2
(ja)
|
2000-08-07 |
2008-07-09 |
富士フイルム株式会社 |
アゾ色素及びそれを含むインクジェット記録用インク、並びにインクジェット記録方法
|
US6525091B2
(en)
|
2001-03-07 |
2003-02-25 |
Telik, Inc. |
Substituted diarylureas as stimulators for Fas-mediated apoptosis
|
WO2002088101A2
(en)
|
2001-04-27 |
2002-11-07 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of bace
|
AU2002309435B2
(en)
|
2001-06-11 |
2008-08-14 |
Biovitrum Ab (Publ) |
Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes
|
HUP0402352A2
(hu)
|
2001-06-19 |
2005-02-28 |
Bristol-Myers Squibb Co. |
Foszfodiészteráz (PDE) 7 inhibitorként alkalmazható pirimidinszármazékok és ezeket tartalmazó gyógyszerkészítmények
|
DE60238066D1
(de)
|
2001-08-17 |
2010-12-02 |
Basf Se |
Triazinderivate und deren verwendung als sonnenschutzmittel
|
JP4753336B2
(ja)
|
2001-09-04 |
2011-08-24 |
日本化薬株式会社 |
新規アリル化合物及びその製法
|
US6723340B2
(en)
|
2001-10-25 |
2004-04-20 |
Depomed, Inc. |
Optimal polymer mixtures for gastric retentive tablets
|
US6878196B2
(en)
|
2002-01-15 |
2005-04-12 |
Fuji Photo Film Co., Ltd. |
Ink, ink jet recording method and azo compound
|
US20040067234A1
(en)
|
2002-07-11 |
2004-04-08 |
Paz Einat |
Isocitrate dehydrogenase and uses thereof
|
EP1546121B1
(en)
|
2002-07-18 |
2012-08-29 |
Janssen Pharmaceutica NV |
Substituted triazine kinase inhibitors
|
JP2004083610A
(ja)
|
2002-08-22 |
2004-03-18 |
Fuji Photo Film Co Ltd |
インクセット、インクカートリッジ、記録方法、プリンター及び記録物
|
JP2004107220A
(ja)
|
2002-09-13 |
2004-04-08 |
Mitsubishi Pharma Corp |
TNF−α産生抑制剤
|
CL2003002353A1
(es)
|
2002-11-15 |
2005-02-04 |
Vertex Pharma |
Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic
|
WO2004050033A2
(en)
|
2002-12-02 |
2004-06-17 |
Arqule, Inc. |
Method of treating cancers
|
US7282568B2
(en)
|
2002-12-16 |
2007-10-16 |
Medarex, Inc. |
Human monoclonal antibodies against interleukin 8 (IL-8)
|
CA2513399A1
(en)
|
2003-01-10 |
2004-07-29 |
Threshold Pharmaceuticals, Inc. |
Treatment of cancer with 2-deoxyglucose
|
US7358262B2
(en)
|
2003-01-29 |
2008-04-15 |
Whitehead Institute For Biomedical Research |
Identification of genotype-selective anti-tumor agents
|
WO2004073619A2
(en)
|
2003-02-14 |
2004-09-02 |
Smithkline Beecham Corporation |
Ccr8 antagonists
|
WO2004074438A2
(en)
|
2003-02-14 |
2004-09-02 |
Smithkline Beecham Corporation |
Ccr8 antagonists
|
US7038038B2
(en)
|
2003-03-17 |
2006-05-02 |
Pharmion Corporation |
Synthesis of 5-azacytidine
|
US6887855B2
(en)
|
2003-03-17 |
2005-05-03 |
Pharmion Corporation |
Forms of 5-azacytidine
|
US6943249B2
(en)
|
2003-03-17 |
2005-09-13 |
Ash Stevens, Inc. |
Methods for isolating crystalline Form I of 5-azacytidine
|
EP1787982B1
(en)
|
2003-04-11 |
2010-05-12 |
High Point Pharmaceuticals, LLC |
11Beta-Hydroxysteroid dehydrogenase type 1 active compounds
|
EP1482418A1
(en)
|
2003-05-28 |
2004-12-01 |
Sap Ag |
A data processing method and system
|
AU2004263148B2
(en)
|
2003-08-06 |
2008-08-21 |
Vertex Pharmaceuticals, Incorporated |
Aminotriazole compounds useful as inhibitors of protein kinases
|
EP1689722A2
(en)
|
2003-10-10 |
2006-08-16 |
Bayer Pharmaceuticals Corporation |
4-aminopyrimidine derivatives for treatment of hyperproliferative disorders
|
US20070196395A1
(en)
|
2003-12-12 |
2007-08-23 |
Mackerell Alexander |
Immunomodulatory compounds that target and inhibit the py'binding site of tyrosene kinase p56 lck sh2 domain
|
EP1708712A1
(en)
|
2003-12-24 |
2006-10-11 |
Scios, Inc. |
Treatment of malignant gliomas with tgf-beta inhibitors
|
JP2005264016A
(ja)
|
2004-03-19 |
2005-09-29 |
Fuji Photo Film Co Ltd |
インクジェット記録用インク、インクセット及びインクジェット記録方法
|
US7335770B2
(en)
|
2004-03-24 |
2008-02-26 |
Reddy U5 Therapeutics, Inc. |
Triazine compounds and their analogs, compositions, and methods
|
US7192781B2
(en)
|
2004-04-13 |
2007-03-20 |
Pharmion Corporation |
Methods for stabilizing 5-azacytidine in plasma
|
GB0412526D0
(en)
|
2004-06-05 |
2004-07-14 |
Leuven K U Res & Dev |
Type 2 diabetes
|
AR051094A1
(es)
|
2004-09-20 |
2006-12-20 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
|
CA2581623A1
(en)
|
2004-09-23 |
2006-03-30 |
Reddy Us Therapeutics, Inc. |
Novel pyridine compounds, process for their preparation and compositions containing them
|
WO2006038594A1
(ja)
|
2004-10-04 |
2006-04-13 |
Ono Pharmaceutical Co., Ltd. |
N型カルシウムチャネル阻害薬
|
WO2006070198A1
(en)
|
2004-12-30 |
2006-07-06 |
Astex Therapeutics Limited |
Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
|
KR20070107061A
(ko)
|
2005-01-25 |
2007-11-06 |
아스트라제네카 아베 |
화학적 화합물
|
MX2007012548A
(es)
|
2005-04-11 |
2008-03-11 |
Savient Pharmaceuticals Inc |
Formas variantes de urato oxidasa y uso de las mismas.
|
EP2687608B1
(en)
|
2005-06-08 |
2017-02-08 |
Millennium Pharmaceuticals, Inc. |
Methods for the identification, assessment, and treatment of patients with cancer therapy
|
GB0513702D0
(en)
|
2005-07-04 |
2005-08-10 |
Sterix Ltd |
Compound
|
NZ565749A
(en)
|
2005-08-26 |
2010-12-24 |
Serono Lab |
Pyrazine derivatives and use as PI3K inhibitors
|
US8133900B2
(en)
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
TW200815426A
(en)
|
2006-06-28 |
2008-04-01 |
Astrazeneca Ab |
New pyridine analogues II 333
|
US8343548B2
(en)
|
2006-08-08 |
2013-01-01 |
Shin-Etsu Chemical Co., Ltd. |
Solid dosage form comprising solid dispersion
|
US20100297673A1
(en)
|
2006-09-20 |
2010-11-25 |
Reddy Us Therapeutics |
Methods and compositions for upregulation of peroxiredoxin activity
|
US20080109846A1
(en)
|
2006-10-23 |
2008-05-08 |
Ewertz C Christian |
System and method for audiovisual content playback
|
JP2010508300A
(ja)
|
2006-10-26 |
2010-03-18 |
フライン、ギャリー・エー. |
アクアポリン修飾因子並びに浮腫および体液平衡異常の治療のためのそれらの使用方法
|
HUP0600810A3
(en)
|
2006-10-27 |
2008-09-29 |
Richter Gedeon Nyrt |
New sulfonamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
|
PE20081229A1
(es)
|
2006-12-01 |
2008-08-28 |
Merck & Co Inc |
Antagonistas de receptor de orexina de diazepam sustituido
|
CN101679371A
(zh)
|
2006-12-04 |
2010-03-24 |
艾美罗股份公司 |
作为腺苷受体拮抗剂的取代的嘧啶
|
WO2008073670A2
(en)
|
2006-12-08 |
2008-06-19 |
Millennium Pharmaceuticals, Inc. |
Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor
|
CA2672893C
(en)
|
2006-12-15 |
2016-02-23 |
Abraxis Bioscience, Inc. |
Triazine derivatives and their therapeutical applications
|
KR101505215B1
(ko)
|
2007-04-30 |
2015-03-23 |
프로메틱 바이오사이언시즈 인코포레이티드 |
트리아진 유도체, 상기 유도체를 함유하는 조성물, 및 상기 유도체를 사용한 암 및 자가면역 질환의 치료 방법
|
JP2010529193A
(ja)
|
2007-06-11 |
2010-08-26 |
ミイカナ セラピューティクス インコーポレイテッド |
置換ピラゾール化合物
|
US8299057B2
(en)
|
2007-07-20 |
2012-10-30 |
Nerviano Medical Sciences S.R.L. |
Substituted indazole derivatives active as kinase inhibitors
|
CN101808693A
(zh)
|
2007-07-25 |
2010-08-18 |
百时美施贵宝公司 |
三嗪激酶抑制剂
|
TW200906818A
(en)
|
2007-07-31 |
2009-02-16 |
Astrazeneca Ab |
Chemical compounds
|
US20100234389A1
(en)
|
2007-10-10 |
2010-09-16 |
Takeda Pharmaceutical Company Limited |
Amide compound
|
AU2008345225A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
GB0805477D0
(en)
|
2008-03-26 |
2008-04-30 |
Univ Nottingham |
Pyrimidines triazines and their use as pharmaceutical agents
|
JP5277685B2
(ja)
|
2008-03-26 |
2013-08-28 |
富士ゼロックス株式会社 |
電子写真感光体、画像形成装置、プロセスカートリッジ及び画像形成方法
|
US20090281089A1
(en)
|
2008-04-11 |
2009-11-12 |
Genentech, Inc. |
Pyridyl inhibitors of hedgehog signalling
|
CN101575408B
(zh)
|
2008-05-09 |
2013-10-30 |
Mca技术有限公司 |
用作阻燃剂和光稳定剂的聚三嗪基化合物
|
EP4327888A3
(en)
*
|
2008-05-15 |
2024-05-22 |
Celgene Corporation |
Oral formulations of cytidine analogs and methods of use thereof
|
FR2932483A1
(fr)
|
2008-06-13 |
2009-12-18 |
Cytomics Systems |
Composes utiles pour le traitement des cancers.
|
WO2010007756A1
(ja)
|
2008-07-14 |
2010-01-21 |
塩野義製薬株式会社 |
Ttk阻害作用を有するピリジン誘導体
|
WO2010028179A1
(en)
|
2008-09-03 |
2010-03-11 |
Dr. Reddy's Laboratories Ltd. |
Heterocyclic compounds as gata modulators
|
EP2326735B1
(en)
|
2008-09-03 |
2016-11-16 |
The Johns Hopkins University |
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
|
JP2010079130A
(ja)
|
2008-09-29 |
2010-04-08 |
Fuji Xerox Co Ltd |
電子写真感光体、プロセスカートリッジ、及び画像形成装置
|
WO2010059239A2
(en)
|
2008-11-21 |
2010-05-27 |
Millennium Pharmaceuticals, Inc |
Lactate salt of 4-(6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disorders
|
JP2010181540A
(ja)
|
2009-02-04 |
2010-08-19 |
Fuji Xerox Co Ltd |
電子写真感光体、プロセスカートリッジ、及び画像形成装置
|
MY155374A
(en)
|
2009-02-06 |
2015-10-15 |
Nippon Shinyaku Co Ltd |
Aminopyrazine derivative and medicine
|
AU2010223919B2
(en)
|
2009-03-13 |
2016-03-31 |
Les Laboratoires Servier |
Methods and compositions for cell-proliferation-related disorders
|
ES2619557T3
(es)
|
2009-05-04 |
2017-06-26 |
Agios Pharmaceuticals, Inc. |
Activadores de PKM2 para uso en el tratamiento del cáncer
|
WO2010130638A1
(en)
|
2009-05-14 |
2010-11-18 |
Evotec Ag |
Sulfonamide compounds, pharmaceutical compositions and uses thereof
|
KR101460095B1
(ko)
|
2009-06-08 |
2014-11-10 |
캘리포니아 캐피탈 에쿼티, 엘엘씨 |
트리아진 유도체와 이들의 치료적 용도
|
EP2440054A4
(en)
|
2009-06-09 |
2012-12-12 |
California Capital Equity Llc |
PYRIDILTRIA INHIBITOR OF HEDGEHOG SIGNALING
|
EP2440056A4
(en)
|
2009-06-09 |
2012-12-05 |
California Capital Equity Llc |
DERIVATIVES OF UREIDOPHENYL SUBSTITUTED TRIAZINE AND THERAPEUTIC APPLICATIONS THEREOF
|
SG10201403696UA
(en)
|
2009-06-29 |
2014-10-30 |
Agios Pharmaceuticals Inc |
Therapeutic compounds and compositions
|
WO2011005209A1
(en)
|
2009-07-10 |
2011-01-13 |
Milux Holding S.A. |
Knee joint device and method
|
US20120157471A1
(en)
|
2009-09-01 |
2012-06-21 |
Pfizer Inc. |
Benzimidazole derivatives
|
WO2011032169A2
(en)
|
2009-09-14 |
2011-03-17 |
Phusis Therapeutics Inc. |
Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
|
JP5473851B2
(ja)
|
2009-09-30 |
2014-04-16 |
富士フイルム株式会社 |
高分子フィルム、位相差フィルム、偏光板及び液晶表示装置
|
US8652534B2
(en)
|
2009-10-14 |
2014-02-18 |
Berry Pharmaceuticals, LLC |
Compositions and methods for treatment of mammalian skin
|
WO2011050210A1
(en)
|
2009-10-21 |
2011-04-28 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
CN105153188B
(zh)
|
2009-10-22 |
2018-06-01 |
法博太科制药有限公司 |
抗纤维化剂的稠环类似物
|
JP5967827B2
(ja)
|
2009-12-09 |
2016-08-10 |
アジオス ファーマシューティカルズ, インコーポレイテッド |
Idh変異体をもつことを特徴とする癌治療用の治療的活性化合物
|
NZ578968A
(en)
|
2010-02-10 |
2011-03-31 |
Allans Sheetmetal And Engineering Services |
Fuel feed system for a pellet fire
|
WO2011123618A1
(en)
|
2010-04-01 |
2011-10-06 |
Agios Pharmaceuticals, Inc. |
Methods of identifying a candidate compound
|
WO2011143160A2
(en)
|
2010-05-10 |
2011-11-17 |
The Johns Hopkins University |
Metabolic inhibitor against tumors having an idh mutation
|
WO2012006506A1
(en)
|
2010-07-09 |
2012-01-12 |
Massachusetts Institute Of Technology |
Metabolic gene, enzyme, and flux targets for cancer therapy
|
WO2012009678A1
(en)
|
2010-07-16 |
2012-01-19 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compositions and their method of use
|
KR20140009181A
(ko)
|
2010-10-21 |
2014-01-22 |
바이오마린 파머수티컬 인크. |
결정질의 (8s,9r)-5-플루오로-8-(4-플루오로페닐)-9-(1-메틸-1h-1,2,4-트리아졸-5-일)-8,9-디하이드로-2h-피리도[4,3,2-de]프탈라진-3(7h)-온 토실레이트 염
|
WO2012078288A2
(en)
|
2010-11-08 |
2012-06-14 |
Washington University |
Methods of determining risk of adverse outcomes in acute myeloid leukemia
|
AU2011336764B2
(en)
|
2010-11-29 |
2017-02-23 |
Galleon Pharmaceuticals, Inc. |
Novel compounds as respiratory stimulants for treatment of breathing control disorders or diseases
|
TWI549947B
(zh)
|
2010-12-29 |
2016-09-21 |
阿吉歐斯製藥公司 |
治療化合物及組成物
|
CA2825152A1
(en)
|
2011-01-31 |
2012-08-09 |
Celgene Corporation |
Pharmaceutical compositions of cytidine analogs and methods of use thereof
|
WO2012173682A2
(en)
|
2011-03-29 |
2012-12-20 |
The Broad Institute, Inc. |
Compounds and methods for the treatment of isocitrate dehydrognase related diseases
|
US9404081B2
(en)
|
2011-05-03 |
2016-08-02 |
Agios Pharmaceuticals, Inc. |
Pyruvate kinase activators for use in therapy
|
TWI555737B
(zh)
|
2011-05-24 |
2016-11-01 |
拜耳知識產權公司 |
含有硫醯亞胺基團之4-芳基-n-苯基-1,3,5-三氮雜苯-2-胺
|
CA2834610A1
(en)
*
|
2011-06-06 |
2012-12-13 |
Merck Sharp & Dohme Corp. |
Rna interference mediated inhibition of isocitrate dehydrogenase (idh1) gene expression
|
CN102827170A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
CN102827073A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
WO2013004332A1
(en)
|
2011-07-07 |
2013-01-10 |
Merck Patent Gmbh |
Substituted azaheterocycles for the treatment of cancer
|
US10441577B2
(en)
|
2011-07-08 |
2019-10-15 |
Helmholtz Zentrum Fuer Infektionsforschung |
Medicament for treatment of liver cancer
|
WO2013016206A1
(en)
|
2011-07-22 |
2013-01-31 |
University Of Louisville Research Foundation, Inc. |
Anti-biofilm compounds
|
CN102659765B
(zh)
|
2011-12-31 |
2014-09-10 |
沈阳药科大学 |
嘧啶及三嗪类化合物的制备方法和应用
|
JP6411895B2
(ja)
|
2012-01-06 |
2018-10-24 |
アジオス ファーマシューティカルズ, インコーポレイテッド |
治療活性化合物およびその使用方法
|
US9474779B2
(en)
|
2012-01-19 |
2016-10-25 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compositions and their methods of use
|
US20150087600A1
(en)
|
2012-01-19 |
2015-03-26 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
EP2634259A1
(en)
|
2012-03-01 |
2013-09-04 |
Deutsches Krebsforschungszentrum |
Means and methods for the determination of (D)-2-hydroxyglutarate (D2HG)
|
CN104169260A
(zh)
|
2012-03-09 |
2014-11-26 |
卡尔那生物科学株式会社 |
新三嗪衍生物
|
US20150031641A1
(en)
|
2012-03-12 |
2015-01-29 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for the diagnosis, prognosis and treatment of acute myeloid leukemia
|
WO2014015422A1
(en)
|
2012-07-27 |
2014-01-30 |
Ontario Institute For Cancer Research |
Cellulose-based nanoparticles for drug delivery
|
CA2888360A1
(en)
|
2012-10-15 |
2014-04-24 |
Agios Pharmaceuticals, Inc. |
Therapeutic compounds and compositions
|
WO2015003360A2
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
US9579324B2
(en)
|
2013-07-11 |
2017-02-28 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
US20150031627A1
(en)
|
2013-07-25 |
2015-01-29 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
WO2015127172A1
(en)
|
2014-02-20 |
2015-08-27 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
WO2015127173A1
(en)
|
2014-02-20 |
2015-08-27 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
EP3116491B1
(en)
|
2014-03-14 |
2021-05-05 |
Agios Pharmaceuticals, Inc. |
Pharmaceutical compositions of therapeutically active compounds
|
EA036325B1
(ru)
|
2014-03-14 |
2020-10-27 |
Аджиос Фармасьютикалз, Инк. |
Фармацевтическая композиция на основе твердой дисперсии ингибитора idh1
|
MX2018004599A
(es)
*
|
2015-10-15 |
2018-09-21 |
Celgene Corp |
Terapia de combinacion para el tratamiento de neoplasias malignas.
|
AU2016338552B2
(en)
|
2015-10-15 |
2022-04-28 |
Les Laboratoires Servier |
Combination therapy for treating malignancies
|
PL3362066T3
(pl)
|
2015-10-15 |
2022-05-02 |
Les Laboratoires Servier |
Terapia skojarzona do leczenia nowotworów złośliwych
|
CN108883184A
(zh)
|
2015-12-04 |
2018-11-23 |
安吉奥斯医药品有限公司 |
治疗恶性肿瘤的方法
|
US20190046512A1
(en)
|
2016-02-26 |
2019-02-14 |
Agios Pharmaceuticals, Inc. |
Idh1 inhibitors for the treatment of haematological malgnancies and solid tumors
|
CA3036384A1
(en)
*
|
2016-09-14 |
2018-03-22 |
Gilead Sciences, Inc. |
Syk inhibitors
|